பிரஞ்சு நெறிமுறைகள் குழு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from பிரஞ்சு நெறிமுறைகள் குழு. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In பிரஞ்சு நெறிமுறைகள் குழு Today - Breaking & Trending Today

French scientist Didier Raoult tries to silence whistle-blower over discredited COVID-19 hydroxychloroquine claims

French scientist Didier Raoult tries to silence whistle-blower over discredited COVID-19 hydroxychloroquine claims
French microbiologist Dr. Didier Raoult, who published a now-discredited paper in March 2020 claiming that hydroxychloroquine was effective at treating COVID-19, has threatened legal action against scientists criticizing his research. These include Elizabeth Bik, the whistleblower who first exposed methodological inconsistencies in Raoult’s research, and Boris Barbour, who runs the not-for-profit website
Pubpeer allowing scientists to review each other’s work.
Dr. Didier Raoult (AP Photo/Christophe Ena)
On May 18, an open letter supporting Bik against Raoult’s attack titled “Scientists stand up to protect academic whistleblowers and post-publication peer review” was published. It has since been signed by over 1,000 scientists across the globe, working across multiple disciplines. ....

United Kingdom , Eric Chabri , Paul Garner , Boris Barbour , Donald Trump , Didier Raoult , Jair Bolsonaro , Cochrane Infectious Disease Group , French Ethics Committee On , Elizabeth Bik , French Ethics Committee , Infectious Diseases , Emmanuel Macron , British Medical Journal , Covid 19 , Didier Raoult , Elizabeth Bik , Jm Rolain , Open Letter , Onni Besançon , Ric Chabrière , ஒன்றுபட்டது கிஂக்டம் , பால் கார்னர் , டொனால்ட் துருப்பு , ஜெயர் போல்சனாரோ , கோக்ரேன் தொற்று நோய் குழு ,

VALBIOTIS Releases Its 2020 Annual Results

VALBIOTIS Releases Its 2020 Annual Results
2020 highlights and results
Global strategic partnership with Nestlé Health Science for the development and marketing of TOTUM-63, a plant-based active substance with clinically proven metabolic health benefits in prediabetic subjects.
Launch of REVERSE-IT, a global pivotal Phase II/III clinical trial of TOTUM-63 for reducing Type 2 Diabetes risk factors.
New milestones achieved with TOTUM-070, a plant-based active substance for lowering LDL-cholesterol, a risk factor for cardiovascular disease.
€14.6m in cash as at December 31, 2020.
Post-balance sheet events and outlook
Important milestones are expected to be reached in the development of TOTUM-070 (reduction in blood LDL-cholesterol levels). ....

United States , Carole Rocher Marc Delaunay , European Association For The Study Of Diabetes , European Regional Development Fund , Health Products Safety , American Heart Association , European Society Of Hypertension , Health Science , French National Agency For Medicines , International Society Of Hypertension , American Diabetes Association , Research Development , Young Innovative Company , Research Tax Credit , European Union , Innovative Company , French Ethics Committee , Regulatory News , First Patient Visit , French National Agency , European Association , Management Board , Statutory Auditor , European Society , International Society , French Financial Markets Regulator ,

Inotrems COVID-19 Phase IIa Clinical Trial Declared National Priority Research by the French Governments Clinical Trial Council

Inotrems COVID-19 Phase IIa Clinical Trial Declared National Priority Research by the French Governments Clinical Trial Council
financialbuzz.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialbuzz.com Daily Mail and Mail on Sunday newspapers.

United States , Jean Jacques Garaud , Research National Priority , National Priority Research , Roche Group , Scientific Council , French Ethics Committee , Jacques Garaud , North American , ஒன்றுபட்டது மாநிலங்களில் , ஜீன் ஜாக்ஸ் காரௌத் , ஆராய்ச்சி தேசிய ப்ரையாரிடீ , தேசிய ப்ரையாரிடீ ஆராய்ச்சி , ரோச் குழு , அறிவியல் சபை , பிரஞ்சு நெறிமுறைகள் குழு , ஜாக்ஸ் காரௌத் , வடக்கு அமெரிக்கன் ,

Inotrem's COVID-19 Phase IIa Clinical Trial Declared "National Priority Research" by the French Government's Clinical Trial Council

Press release content from Business Wire. The AP news staff was not involved in its creation.
Inotrem’s COVID-19 Phase IIa Clinical Trial Declared “National Priority Research” by the French Government’s Clinical Trial Council
December 24, 2020 GMT
PARIS (BUSINESS WIRE) Dec 24, 2020
Inotrem S.A., a biotechnology company specialized in the development of immunotherapies targeting the TREM-1 pathway, announces today that its Phase IIa study of nangibotide, the company’s lead product, for the treatment of severe forms of COVID-19 has been declared “National Priority Research” by the French government steering committee for therapeutic clinical trials and other research (CAPNET). ....

United States , Jean Jacques Garaud , Research National Priority , National Priority Research , Roche Group , Scientific Council , French Ethics Committee , Jacques Garaud , North American , Business Wire , Products And Services , Coronavirus Pandemic , Product Testing , Health Care Industry , Lung Disease , Medical Biotechnology Industry , Medical Research , Clinical Trials , Western Europe , Infectious Diseases , Corporate News , North America , Diseases And Conditions , Government And Politics , ஒன்றுபட்டது மாநிலங்களில் , ஜீன் ஜாக்ஸ் காரௌத் ,

AKTIONÄR-Hot-Stock Abivax: 134 Prozent im Plus – was ist da los?

AKTIONÄR-Hot-Stock Abivax: 134 Prozent im Plus – was ist da los?
deraktionaer.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from deraktionaer.de Daily Mail and Mail on Sunday newspapers.

Committee Of French Government , European Biotech Companies , French Ethics Committee , French Approval Authority , French Government , Wednesday Morning , Product Portfolio , Immune System , Conducted Committee , Coming Soon , Advisory Board , Patient Recruitment , Subject To Availability , Study Results , Clinical Studies , Approval Process , Reception Her Patient , Gains Run , Share Reserved , பிரஞ்சு நெறிமுறைகள் குழு , பிரஞ்சு அரசு , புதன்கிழமை காலை , ப்ராடக்ட் போர்ட்‌ஃபோலீயோ , நோய் எதிர்ப்பு சக்தி அமைப்பு , வருகிறது விரைவில் , நோயாளி ஆட்சேர்ப்பு ,